As of Aug 26
| +0.79 / +0.96%|
The 16 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 91.75, with a high estimate of 106.00 and a low estimate of 65.00. The median estimate represents a +10.40% increase from the last price of 83.11.
The current consensus among 21 polled investment analysts is to Hold stock in Charles River Laboratories International Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.